C09DA04 |
B |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
10874 |
27222/1 |
CO APROVEL |
|
28 |
Tablet, film coated |
Oral |
Mersaco |
Sanofi Winthrop Industrie |
France |
658,483 L.L |
23.08 |
A1 |
Sanofi Aventis Groupe |
France |
2/4/2025 |
|
C09DA04 |
B |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
11903 |
128423/1 |
CO APROVEL |
|
28 |
Tablet, film coated |
Oral |
Mersaco |
Sanofi Winthrop Industrie |
France |
658,483 L.L |
23.08 |
A1 |
Sanofi Winthrop Industrie |
France |
2/4/2025 |
|
C09DA04 |
G |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
10528 |
130517/1 |
CONVERIUM PLUS |
|
30 |
Tablet, film coated |
Oral |
New Allpharma |
Medochemie Ltd |
Cyprus |
395,090 L.L |
23.08 |
A1 |
Medochemie Ltd |
Cyprus |
2/4/2025 |
|
C09DA04 |
G |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
7674 |
30514/1 |
GIZLAN-PLUS |
|
30 |
Tablet, film coated |
Oral |
Sadco |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
395,090 L.L |
23.08 |
A1 |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
2/4/2025 |
|
C09DA04 |
G |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
8512 |
185801/13 |
IBECARD PLUS 150/12.5 |
|
30 |
Tablet, film coated |
Oral |
IPS "Integrated Pharma Solutions SARL" |
Benta SAL |
Lebanon |
559,294 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
C09DA04 |
G |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
10588 |
17721/1 |
IRBAVEL PLUS 150/12.5 |
|
30 |
Tablet, film coated |
Oral |
Benta Trading Co s.a.l. |
Benta SAL |
Lebanon |
559,294 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
C09DA04 |
G |
Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg |
6224 |
167546/10 |
ZIOREL PLUS |
|
30 |
Tablet, film coated |
Oral |
Droguerie de l'Union |
Algorithm S.A.L. |
Lebanon |
559,294 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|